Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.
about
Role of bone-anabolic agents in the treatment of breast cancer bone metastasesRecent advances in bone regeneration using adult stem cellsSerum parathyroid hormone is a new potential risk factor in multiple myelomaCYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone diseaseBone anabolic agents for the treatment of multiple myeloma.Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study.Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblastTherapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthMyeloma bone disease: pathogenesis, current treatments and future targets.The osteoblastic niche in the context of multiple myeloma.Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.Prevention of breast cancer skeletal metastases with parathyroid hormone.The Proteasome and Myeloma-Associated Bone Disease.Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.New agents in the Treatment of Myeloma Bone Disease.Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis.PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
P2860
Q26822732-8CADB361-EEFE-4423-B586-1EC87EDD4B1CQ26824117-358C8BCA-45AF-4E84-B16A-EEB36D2ACE83Q33746923-5C741D02-40CF-4770-A3CC-39FA83B8EA12Q34292995-AF932149-050F-4AEF-B12C-C5DEBE7F68F5Q35603116-253E6D4A-841A-4A7F-B1DF-060F72940582Q35778467-D712EA55-4B35-4617-A5D7-DB21BAEE115FQ36086488-D33E2573-0E33-4A98-8E66-5FA43E14141CQ36092153-F5CA551D-4DEA-4AFF-9ADB-6D5073AACC77Q38246241-64BCCA46-9182-4815-AAC7-70D7E073A8DEQ38271428-E6170E34-1B54-4606-94C7-4C0555D1D2F0Q38700342-A114B9B0-0002-42B0-8A31-83B972F62CB4Q38820789-6594D450-B351-4816-A6F9-9E679A69A98DQ39162516-76DE272F-F0B7-4C10-97E4-6E5B61FA8535Q42017254-957ECF50-7A30-45CF-BA56-F1B07BC65ABFQ47696279-BFDC80BB-917F-4CE4-877A-71E4819734D8Q48986728-298E7986-D0E6-4FDF-AC97-EDABE1146945Q50323850-229CA299-682C-4A11-9098-E7E34696D786Q54448123-42D245DC-C07C-4B29-A659-42A87A65E795Q55235695-8E95CE57-DCB7-42EC-AB5A-6830CD93D5BBQ57109145-8D6E0B3B-3AA2-41E1-85E1-F4E57C461956
P2860
Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Consequences of daily administ ...... ing of whole myelomatous bone.
@ast
Consequences of daily administ ...... ing of whole myelomatous bone.
@en
Consequences of daily administ ...... ing of whole myelomatous bone.
@nl
type
label
Consequences of daily administ ...... ing of whole myelomatous bone.
@ast
Consequences of daily administ ...... ing of whole myelomatous bone.
@en
Consequences of daily administ ...... ing of whole myelomatous bone.
@nl
prefLabel
Consequences of daily administ ...... ing of whole myelomatous bone.
@ast
Consequences of daily administ ...... ing of whole myelomatous bone.
@en
Consequences of daily administ ...... ing of whole myelomatous bone.
@nl
P2093
P2860
P1433
P1476
Consequences of daily administ ...... ing of whole myelomatous bone.
@en
P2093
Angela Pennisi
John D Shaughnessy
Sharmin Khan
Yuping Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0015233
P407
P577
2010-12-20T00:00:00Z